Evidence mapPaperPMID 41473159Full record

ArticleFrontiers in medicine2025

Identifying sepsis susceptibility genes in post-surgical patients using an artificial intelligence approach.

Fernando Vaquerizo-Villar, Tamara Hernandez-Beeftink, María Heredia-Rodríguez, Esther Gómez-Sánchez, Mario Lorenzo-López, Rocío López-Herrero, Miguel Bardaji-Carrillo, Álvaro Tamayo-Velasco, Marta Martín-Fernández, Laura Sánchez-de-Prada and 18 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Fernando Vaquerizo-Villar *Department of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Tamara Hernandez-Beeftink *Division of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, United Kingdom.
María Heredia-RodríguezBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Esther Gómez-SánchezDepartment of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Mario Lorenzo-LópezDepartment of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Rocío López-HerreroDepartment of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Miguel Bardaji-CarrilloDepartment of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Álvaro Tamayo-VelascoBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Marta Martín-FernándezBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Laura Sánchez-de-PradaBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Julián Álvarez-EscuderoDepartment of Anaesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago, Santiago de Compostela, Spain.
Sonia VeirasDepartment of Anaesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago, Santiago de Compostela, Spain.
Aurora BalujaSanitary Research Institute of Santiago (IDIS), Santiago de Compostela, Spain.
Hugo Gonzalo-BenitoBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Pedro Martínez-PazBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Adrián García-ConcejoBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Amanda Fernández-RodríguezBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
María A Jiménez-SousaBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Salvador ResinoBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Laura Martínez-CampeloCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Eva Suárez-PajésResearch Unit, Hospital Universitario Nuestra Señora de Candelaria, Instituto de Investigación Sanitaria de Canarias (IISC), Santa Cruz de Tenerife, Spain.
Inés QuintelaSanitary Research Institute of Santiago (IDIS), Santiago de Compostela, Spain.
Raquel CruzCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Ángel CarracedoServicio de Anestesiología, Hospital Virxe Da Xunqueira, A Coruña, Spain.
Jesús VillarCIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Carlos FloresResearch Unit, Hospital Universitario Nuestra Señora de Candelaria, Instituto de Investigación Sanitaria de Canarias (IISC), Santa Cruz de Tenerife, Spain.
Roberto HorneroBiomedical Engineering Group, University of Valladolid, Valladolid, Spain.
Eduardo TamayoDepartment of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early detection of sepsis is essential for its successful management. Although genome-wide association studies (GWAS) have shown potential in identifying sepsis-related genetic variants, they often involve heterogeneous patient groups and use single-locus analysis methods. Here, we aim to identify new sepsis susceptibility loci in post-surgical patients using an explainable artificial intelligence (XAI) approach applied to GWAS data. Methods: GWAS was performed in 750 post-operative patients with sepsis and 3,500 population controls. We applied a novel XAI-based methodology to GWAS-derived single nucleotide polymorphisms (SNPs) to predict sepsis and prioritize new genetic variants associated with post-operative sepsis susceptibility. We also assessed functional and enrichment effects using empirical data from integrated software tools and datasets, with the top-ranked variants and associated genes. Results: Our XAI-GWAS approach showed a notable performance in predicting post-surgical sepsis and prioritized SNPs (such as rs17653532, rs1575081785, and rs74707084) with higher contribution to post-operative sepsis prediction. It also facilitated the discovery of post-operative sepsis risk loci with important functional implications related to gene expression regulation, DNA replication, cyclic nucleotide signaling, cell proliferation, and cardiac dysfunction. Conclusion: The combination of GWAS and XAI prioritized loci associated with post-operative sepsis susceptibility. The determination of key genes, such as

Indexed as

explainable artificial intelligence (XAI)genome-wide association study (GWAS)personalized medicinesepsissurgical patients

Identifiers

PMID41473159
PMCPMC12745203

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.